AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 59 filers reported holding AVEO PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,625,330 | +82.3% | 1,513,400 | +0.4% | 0.00% | – |
| Q3 2022 | $12,410,000 | +26.0% | 1,507,955 | +0.4% | 0.00% | – |
| Q2 2022 | $9,848,000 | +17.3% | 1,501,317 | 0.0% | 0.00% | – |
| Q1 2022 | $8,392,000 | +22.1% | 1,501,317 | +2.5% | 0.00% | – |
| Q4 2021 | $6,871,000 | -23.7% | 1,465,107 | +0.6% | 0.00% | – |
| Q3 2021 | $9,000,000 | -5.7% | 1,456,230 | +0.6% | 0.00% | – |
| Q2 2021 | $9,541,000 | -5.0% | 1,447,686 | +5.5% | 0.00% | – |
| Q1 2021 | $10,046,000 | +39.0% | 1,372,537 | +9.6% | 0.00% | – |
| Q4 2020 | $7,225,000 | +10.7% | 1,252,147 | +14.0% | 0.00% | – |
| Q3 2020 | $6,524,000 | +16.8% | 1,098,349 | +1.3% | 0.00% | – |
| Q2 2020 | $5,584,000 | +135.8% | 1,084,266 | +65.8% | 0.00% | – |
| Q1 2020 | $2,368,000 | – | 654,008 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |